DC Field | Value | Language |
---|---|---|
dc.contributor.author | H Park | - |
dc.contributor.author | Ayoung Gyeong | - |
dc.contributor.author | H J Lee | - |
dc.contributor.author | Sunghyun Kang | - |
dc.contributor.author | Tae-Sung Yoon | - |
dc.contributor.author | S E Ryu | - |
dc.contributor.author | Dae Gwin Jeong | - |
dc.date.accessioned | 2017-04-19T09:40:32Z | - |
dc.date.available | 2017-04-19T09:40:32Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1054-2523 | - |
dc.identifier.uri | 10.1007/s00044-012-0405-3 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/11377 | - |
dc.description.abstract | Dual-specificity phosphatase 26 (DUSP26) has recently proved to be a promising therapeutical target for the treatment of human cancers. Here, we report the first example for a successful application of the structure-based virtual screening approach to identify nine novel inhibitors of DUSP26. These inhibitors are also screened for having desirable physicochemical properties as drug candidates and reveal a high potency with IC50 values ranging from 8 to 42 μM. Therefore, they deserve consideration for further development by structure-activity relationship (SAR) studies to optimize the anticancer activities. Structural features relevant to the stabilization of the newly identified inhibitors in the active site of DUSP26 are addressed in detail. | - |
dc.publisher | Springer | - |
dc.title | Virtual screening and biochemical evaluation of the inhibitors of dual-specificity phosphatase 26 = DUSP26 저해제의 가상검색과 생화학적 평가 | - |
dc.title.alternative | Virtual screening and biochemical evaluation of the inhibitors of dual-specificity phosphatase 26 | - |
dc.type | Article | - |
dc.citation.title | Medicinal Chemistry Research | - |
dc.citation.number | 8 | - |
dc.citation.endPage | 3910 | - |
dc.citation.startPage | 3905 | - |
dc.citation.volume | 22 | - |
dc.contributor.affiliatedAuthor | Ayoung Gyeong | - |
dc.contributor.affiliatedAuthor | Sunghyun Kang | - |
dc.contributor.affiliatedAuthor | Tae-Sung Yoon | - |
dc.contributor.affiliatedAuthor | Dae Gwin Jeong | - |
dc.contributor.alternativeName | 박황서 | - |
dc.contributor.alternativeName | 경아영 | - |
dc.contributor.alternativeName | 이현주 | - |
dc.contributor.alternativeName | 강성현 | - |
dc.contributor.alternativeName | 윤태성 | - |
dc.contributor.alternativeName | 류성언 | - |
dc.contributor.alternativeName | 정대균 | - |
dc.identifier.bibliographicCitation | Medicinal Chemistry Research, vol. 22, no. 8, pp. 3905-3910 | - |
dc.identifier.doi | 10.1007/s00044-012-0405-3 | - |
dc.subject.keyword | Anticancer agents | - |
dc.subject.keyword | Docking | - |
dc.subject.keyword | DUSP26 | - |
dc.subject.keyword | Inhibitor | - |
dc.subject.keyword | Virtual screening | - |
dc.subject.local | Anticancer Agents | - |
dc.subject.local | Anti-cancer agents | - |
dc.subject.local | anti-cancer agent | - |
dc.subject.local | Anti-cancer agent | - |
dc.subject.local | Anticancer agent | - |
dc.subject.local | Anticancer agents | - |
dc.subject.local | Anticancer Agent | - |
dc.subject.local | anticancer agent | - |
dc.subject.local | docking | - |
dc.subject.local | Docking | - |
dc.subject.local | DUSP26 | - |
dc.subject.local | inhibitors | - |
dc.subject.local | Inhibitors | - |
dc.subject.local | inhibitor | - |
dc.subject.local | Inhibitor | - |
dc.subject.local | Virtual screening | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.